Where I see patients (1)
Selected research
-
Dupilumab Improves Health-Related Quality of Life and Respiratory Symptoms in Patients With COPD and Type 2 Inflammation: BOREAS and NOTUS.
Chest
-
Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials.
The Lancet. Respiratory medicine
-
Multicohort Analysis of Bronchial Epithelial Cell Expression in Healthy Subjects and Patients with Asthma Reveals Four Clinically Distinct Clusters.
American journal of respiratory cell and molecular biology
Clinical trials
Contact me
- Request appointment
- Refer a patient
- (415) 353-2961